Skip to main navigation Skip to search Skip to main content

Trypanocidal activity of β-lactone-γ-lactam proteasome inhibitors

Dietmar Steverding, Xia Wang, Barbara C. M. Potts, Michael A. Palladino

Research output: Contribution to journalArticlepeer-review

Abstract

Four β-lactone -γ- lactam proteasome inhibitors of natural origin were tested for their trypanocidal activities in vitro using culture-adapted bloodstream forms of Trypanosoma brucei. All four compounds displayed activities in the nanomolar range. The most trypanocidal compounds with 50% growth inhibition (GI 50) values of around 3nM were the bromine and iodine analogues of salinosporamide A, a potent proteasome inhibitor produced by the marine actinomycete Salinispora tropica. In general, trypanosomes were more susceptible to the compounds than were human HL-60 cells. The data support the potential of -lactone - lactam proteasome inhibitors for rational anti-trypanosomal drug development.

Original languageEnglish
Pages (from-to)131-134
Number of pages4
JournalPlanta Medica
Volume78
Issue number2
Early online date27 Oct 2011
DOIs
Publication statusPublished - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • β-lactone-γ-lactam proteasome inhibitors
  • sleeping sickness
  • trypanocidals
  • Trypanosoma brucei

Cite this